SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-007060
Filing Date
2023-04-27
Accepted
2023-04-27 16:10:08
Documents
4
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230616xdef14a.htm DEF 14A 559303
2 GRAPHIC tmb-20230616xdef14a_a001.jpg GRAPHIC 5269
3 GRAPHIC tmb-20230616xdef14a_bg001.jpg GRAPHIC 116496
4 GRAPHIC tmb-20230616xdef14a_bg002.jpg GRAPHIC 102278
  Complete submission text file 0001558370-23-007060.txt   869383
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40523 | Film No.: 23856924
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences